In Reply In response to a Viewpoint urging action to improve suicide prevention in health care settings,1 Bastiampillai et al emphasize the effectiveness of lithium (for patients with bipolar disorder) and clozapine (for patients with schizophrenia) in reducing suicide. They note the low prescription rates of both medications in the United States and urge efforts to increase use of these effective treatments as a key suicide prevention strategy.
Hogan MF. Increasing the Use of Lithium and Clozapine in US Suicide Prevention—Reply. JAMA Psychiatry. 2017;74(4):423–424. doi:10.1001/jamapsychiatry.2016.4067
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: